Estimating the impact of vaccines in reducing antimicrobial resistance and antibiotics

  11 October 2024

An extensive assessment of vaccines’ ability to lower antimicrobial resistance (AMR) is given in this research. It highlights the value of vaccinations as an essential instrument for avoiding infections and halting the spread of resistant strains, which lowers the need for medicines. Historically, the emphasis has been mostly on the use of vaccinations to prevent infectious illnesses, with little attention paid to their role in lowering AMR.

This research is unusual in that it provides a thorough evaluation of 44 vaccinations that target 24 infections, including both approved and experimental vaccines. In order to calculate the possible influence of these vaccinations on AMR-related health outcomes, antibiotic use, and financial expenses, a sound technique is incorporated. This paper stands out for its meticulous modeling of the burden avoided by vaccinations.

Further reading: WHO
Author(s): WHO
Healthy Patients  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS

BD





AMR NEWS

Every two weeks in your inbox

Because there should be one newsletter that brings together all One Health news related to antimicrobial resistance: AMR NEWS!

Subscribe

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed